CSIMarket
 


9 Meters Biopharma Inc   (NMTR)
Other Ticker:  
 

9 Meters Biopharma Inc 's Total Debt to Equity

NMTR's quarterly Total Debt to Equity and Total Debt, Equity growth


In I Quarter 2023 9 Meters Biopharma Inc had stockholder deficit.

Within Major Pharmaceutical Preparations industry 9 Meters Biopharma Inc achieved the lowest Total Debt to Equity in the first quarter 2023. While total ranking remained the same in the first quarter 2023 compared to the previous quarter at no. .

Explain Debt to Equity Ratio?
What is the structure of NMTR´s Total Debt?
How valuable is the NMTR´s Equity?


NMTR Total Debt to Equity (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Equity Change - -94.23 % -72.68 % -62.65 % -9.17 %
Y / Y Total Debt Change - - - - -
Total Debt to Equity MRQ - 8.17 1.37 - -
NMTR's Total Ranking # # # # #
Seq. Equity Change - -82.17 % -39.05 % -28.62 % -25.63 %
Seq. Total Debt Change -74.15 % 6.67 % - - -



Total Debt to Equity first quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Total Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
9 Meters Biopharma Inc 's Equity $ -6 Millions Visit NMTR's Balance sheet
9 Meters Biopharma Inc 's Total Debt $ 5 Millions Visit NMTR's Balance sheet
Source of NMTR's Sales Visit NMTR's Sales by Geography


Cumulative 9 Meters Biopharma Inc 's Total Debt to Equity

NMTR's Total Debt to Equity for the trailling 12 Months

NMTR Total Debt to Equity

(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Equity TTM Growth - -94.23 % -72.68 % -62.65 % -9.17 %
Y / Y Total Debt TTM Growth - - - - -
Total Debt to Equity TTM 1.36 0.55 0.17 - -
Total Ranking TTM
Seq. Equity TTM Growth - -82.17 % -39.05 % -28.62 % -25.63 %
Seq. Total Debt TTM Growth -74.15 % 6.67 % - - -


On the trailing twelve months basis During the 12 months period ending I Quarter 2023 company had stockholder deficit.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 19, during the past 12 months, other companies have achieved lower Total Debt to Equity than 9 Meters Biopharma Inc . While total ranking remained unchanged compared to previous 12 month period at no. 171.

Explain Debt to Equity Ratio?
What is the structure of NMTR´s Total Debt?
How valuable is the NMTR´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 20
Healthcare Sector # 49
Within the Market #


trailing twelve months Total Debt to Equity Statistics
High Average Low
10.16 1.83 0
(Mar 31 2019)   (Sep 30 2021)




Companies with similar Total Debt to Equity in the quarter ending Mar 31 2023, within Major Pharmaceutical Preparations Industry Total Debt to EquityMar 31 2023 MRQ Total DebtMar 31 2023 MRQ Equity

Date modified: 2023-05-16T22:28:55+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com